2013
DOI: 10.1016/j.ejpb.2013.09.014
|View full text |Cite
|
Sign up to set email alerts
|

One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
34
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
4
4
1

Relationship

2
7

Authors

Journals

citations
Cited by 55 publications
(38 citation statements)
references
References 37 publications
4
34
0
Order By: Relevance
“…Thus, L-penetratin showed a greater increase in intestinal insulin absorption, and this is consistent with our former results obtained by in situ absorption study (13). Next, we used the CPPs assessed in our previous studies to examine the differences between the abilities of different CPPs to increase insulin absorption (12)(13)(14)(15)22,23). The time profiles for plasma insulin concentration after ileal coadministration of insulin with penetratin, R8, or PenetraMax, and the pharmacokinetic parameters are shown in Fig.…”
Section: Discussionsupporting
confidence: 74%
See 1 more Smart Citation
“…Thus, L-penetratin showed a greater increase in intestinal insulin absorption, and this is consistent with our former results obtained by in situ absorption study (13). Next, we used the CPPs assessed in our previous studies to examine the differences between the abilities of different CPPs to increase insulin absorption (12)(13)(14)(15)22,23). The time profiles for plasma insulin concentration after ileal coadministration of insulin with penetratin, R8, or PenetraMax, and the pharmacokinetic parameters are shown in Fig.…”
Section: Discussionsupporting
confidence: 74%
“…We recently reported our findings of an in silico analysis in which we found that an innovative CPP, "PenetraMax," developed by sequence modification of penetratin, had a superior insulin absorption-enhancing efficiency over the parent penetratin (21,22). A subchronic study of nasal administration of insulin with PenetraMax at two selected concentrations (0.5 and 2.0 mM), which significantly increased the systemic bioavailability of insulin reaching almost 100% relative to subcutaneous insulin administration, found no increase in the risk of detectable local or systemic inflammation and immunogenicity and without causing detectable epithelial membrane damage (23).…”
Section: Introductionmentioning
confidence: 99%
“…As we know, cell penetration and cargo delivery properties of penetratin are well-known facts to scientists involved in the fields of cell permeation and peptide delivery. [12][13][14][15][16][17] According to the promising results reported for a special analog of penetratin in an intranasal insulin delivery (a physical mixture formulation), 18 this 16-amino-acid peptide sequence was synthesized in our peptide laboratory in Khaje Nasir University and purified to more than 95% purity. Table 1 provides the amino acid sequence of penetratin and the newly developed analog of penetratin (PenetraMax) investigated in this study.…”
Section: Methodsmentioning
confidence: 99%
“…Although they have primarily been explored for intracellular drug delivery of, e.g., oligonucleotides (1) or antibodies (2), they may also be suitable candidates for transepithelial drug delivery involving non-covalent complexation with biopharmaceuticals (3). The primary sequence of a CPP is of great importance for its cellpenetrating efficiency.…”
Section: Introductionmentioning
confidence: 99%